Anti-glomerular basement membrane disease: Outcomes of different therapeutic regimens in a large single-center chinese cohort study

Medicine

Volumn 90, Issue 5, 2011, Pages 303-311

  Cui, Zhao ^a,b,c   Zhao, Juan ^a,b,c   Jia, Xiao Yu ^a,b,c   Zhu, Sai Nan ^a   Jin, Qi Zhuang ^a,b,c   Cheng, Xu Yang ^a,b,c   Zhao, Ming Hui ^a,b,c  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b PEKING UNIVERSITY   (China)

^c BEIJING HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; STEROID;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CHILD; CHINESE; CLINICAL FEATURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GLOMERULONEPHRITIS; GOODPASTURE SYNDROME; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; LUNG HEMORRHAGE; MAJOR CLINICAL STUDY; MALE; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SCHOOL CHILD; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CHILD; CHINA; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; MALE; MIDDLE AGED; PLASMAPHERESIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80052475037     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0b013e31822f6f68     Document Type: Article

References (38)

1. Ang C, Savige J, Dawborn J, Miach P, Heale W, Clarke B, Sinclair RS. Anti-glomerular basement membrane (GBM)-antibody-mediated disease with normal renal function. Nephrol Dial Transplant. 1998;13:935-939. (Pubitemid 28161767)
2. Borza DB, Netzer KO, Leinonen A, Todd P, Cervera J, Saus J, Hudson BG. The goodpasture autoantigen. Identification of multiple cryptic epitopes on the NC1 domain of the alpha3(IV) collagen chain. J Biol Chem. 2000;275:6030-6037. (Pubitemid 30115254)
3. Bosch X, Mirapeix E, Font J, Borrellas X, Rodriguez R, Lopez-Soto A, Ingelmo M, Revert L. Prognostic implication of anti-neutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in anti-glomerular basement membrane disease. Clin Nephrol. 1991;36:107-113.
4. Briggs WA, Johnson JP, Teichman S, Yeager HC, Wilson CB. Antiglomerular basement membrane antibody-mediated glomerulonephritis and Goodpasture's syndrome. Medicine (Baltimore). 1979;58:348-361. (Pubitemid 10234878)
5. Chen M, Yu F, Zhang Y, Zhao MH. Antineutrophil cytoplasmic autoantibody-associated vasculitis in older patients. Medicine (Baltimore). 2008;87:203-209.
6. Couser WG. Rapidly progressive glomerulonephritis: classification, pathogenetic mechanisms, and therapy. Am J Kidney Dis. 1988;11:449-464.
7. Cui Z, Wang HY, Zhao MH. Natural autoantibodies against glomerular basement membrane exist in normal human sera. Kidney Int. 2006;69:894-899.
8. Cui Z, Zhao MH. Avidity of anti-glomerular basement membrane autoantibodies was associated with disease severity. Clin Immunol. 2005;116:77-82. (Pubitemid 40733585)
9. Cui Z, Zhao MH, Singh AK, Wang HY. Antiglomerular basement membrane disease with normal renal function. Kidney Int. 2007;72:1403-1408. (Pubitemid 350126772)
10. Cui Z, Zhao MH, Wang SX, Liu G, Zou WZ, Wang HY. Concurrent antiglomerular basement membrane disease and immune complex glomerulonephritis. Ren Fail. 2006;28:7-14. (Pubitemid 43247284)
11. Cui Z, Zhao MH, Xin G, Wang HY. Characteristics and prognosis of Chinese patients with anti-glomerular basement membrane disease. Nephron Clin Pract. 2005;99:c49-55. (Pubitemid 40187049)
12. Daly C, Conlon PJ, Medwar W, Walshe JJ. Characteristics and outcome of anti-glomerular basement membrane disease: a single-center experience. Ren Fail. 1996;18:105-112. (Pubitemid 26073879)
13. de Torrente A, Popovtzer MM, Guggenheim SJ, Schrier RW. Serious pulmonary hemorrhage, glomerulonephritis, and massive steroid therapy. Ann Intern Med. 1975;83:218-219.
14. Erickson SB, Kurtz SB, Donadio JV Jr, Holley KE, Wilson CB, Pineda AA. Use of combined plasmapheresis and immunosuppression in the treatment of Goodpasture's syndrome. Mayo Clin Proc. 1979;54:714-720. (Pubitemid 10157799)
15. Fischer EG, Lager DJ. Anti-glomerular basement membrane glomerulonephritis: a morphologic study of 80 cases. Am J Clin Pathol. 2006;125:445-450. (Pubitemid 43327716)
16. Hellmark T, Johansson C, Wieslander J. Characterization of anti-GBM antibodies involved in Goodpasture's syndrome. Kidney Int. 1994;46:823-829. (Pubitemid 24272041)
17. Hind CR, Paraskevakou H, Lockwood CM, Evans DJ, Peters DK, Rees AJ. Prognosis after immunosuppression of patients with crescentic nephritis requiring dialysis. Lancet. 1983;1:263-265. (Pubitemid 13184279)
18. Hirayama K, Yamagata K, Kobayashi M, Koyama A. Anti-glomerular basement membrane antibody disease in Japan: part of the nationwide rapidly progressive glomerulonephritis survey in Japan. Clin Exp Nephrol. 2008;12:339-347.
19. Jayne D, Rasmussen N, Andrassy K, Bacon P, Tervaert JW, Dadoniene J, Ekstrand A, Gaskin G, Gregorini G, de Groot K, Gross W, Hagen EC, Mirapeix E, Pettersson E, Siegert C, Sinico A, Tesar V, Westman K, Pusey C. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med. 2003;349:36-44. (Pubitemid 36765101)
20. Jindal KK. Management of idiopathic crescentic and diffuse proliferative glomerulonephritis: evidence-based recommendations. Kidney Int Suppl. 1999;70:S33-40.
21. Johnson JP, Whitman W, Briggs WA, Wilson CB. Plasmapheresis and immunosuppressive agents in antibasement membrane antibody-induced Goodpasture's syndrome. Am J Med. 1978;64:354-359. (Pubitemid 8287309)
22. Kelly PT, Haponik EF. Goodpasture syndrome: molecular and clinical advances. Medicine (Baltimore). 1994;73:171-185. (Pubitemid 24245107)
23. Lerner RA, Glassock RJ, Dixon FJ. The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Exp Med. 1967;126:989-1004.
24. Levy JB, Hammad T, Coulthart A, Dougan T, Pusey CD. Clinical features and outcome of patients with both ANCA and anti-GBM antibodies. Kidney Int. 2004;66:1535-1540. (Pubitemid 39298387)
25. Levy JB, Turner AN, Rees AJ, Pusey CD. Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med. 2001;134:1033-1042. (Pubitemid 32488657)
26. Li FK, Tse KC, Lam MF, Yip TP, Lui SL, Chan GS, ChanKW, Chan EY, Choy BY, Lo WK, Chan TM, Lai KN. Incidence and outcome of antiglomerular basement membrane disease in Chinese. Nephrology (Carlton). 2004;9:100-104. (Pubitemid 38530453)
27. Lionaki S, Jennette JC, Falk RJ. Anti-neutrophil cytoplasmic (ANCA) and anti-glomerular basement membrane (GBM) autoantibodies in necrotizing and crescentic glomerulonephritis. Semin Immunopathol. 2007;29:459-474. (Pubitemid 350077264)
28. Liu N, Zhao MH, Zhang YK, Zheng X, Wang HY. Anti-glomerular basement membrane autoantibodies in Chinese patients with rapidly progressive glomerulonephritis and their clinical relevance. Chin J Nephrol. 1998;14:292-295.
29. Merkel F, Pullig O, Marx M, Netzer KO, Weber M. Course and prognosis of anti-basement membrane antibody (anti-BM-Ab)-mediated disease: report of 35 cases. Nephrol Dial Transplant. 1994;9:372-376. (Pubitemid 24136268)
30. Pusey CD. Anti-glomerular basement membrane disease. Kidney Int. 2003;64:1535-1550. (Pubitemid 37153829)
31. Rossen RD, Duffy J, McCredie KB, Reisberg MA, Sharp JT, Hersh EM, Eknoyan G, Suki WN. Treatment of Goodpasture syndrome with cyclophosphamide, prednisone and plasma exchange transfusions. Clin Exp Immunol. 1976;24:218-222.
32. Savage CO, Pusey CD, Bowman C, Rees AJ, Lockwood CM. Antiglomerular basement membrane antibody mediated disease in the British Isles 1980-4. Br Med J (Clin Res Ed). 1986;292:301-304. (Pubitemid 16144622)
33. Segelmark M, Hellmark T, Wieslander J. The prognostic significance in Goodpasture's disease of specificity, titre and affinity of anti-glomerular- basement-membrane antibodies. Nephron Clin Pract. 2003;94:c59-68.
34. Simpson IJ, Doak PB, Williams LC, Blacklock HA, Hill RS, Teague CA, Herdson PB, Wilson CB. Plasma exchange in Goodpasture's syndrome. Am J Nephrol. 1982;2:301-311. (Pubitemid 13181772)
35. Walker RG, Scheinkestel C, Becker GJ, Owen JE, Dowling JP, Kincaid-Smith P. Clinical and morphological aspects of the management of crescentic anti-glomerular basement membrane antibody (anti-GBM) nephritis/Goodpasture's syndrome. Q J Med. 1985;54:75-89. (Pubitemid 15134931)
36. Wilson CB, Dixon FJ. Anti-glomerular basement membrane antibody-induced glomerulonephritis. Kidney Int. 1973;3:74-89.
37. Zhao J, Yang R, Cui Z, Chen M, Zhao MH, Wang HY. Characteristics and outcome of Chinese patients with both antineutrophil cytoplasmic antibody and antiglomerular basement membrane antibodies. Nephron Clin Pract. 2007;107:c56-62. (Pubitemid 47557269)
38. Zimmerman SW, Varanasi UR, Hoff B. Goodpasture's syndrome with normal renal function. Am J Med. 1979;66:163-171. (Pubitemid 9089840)